May 4 |
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
|
May 3 |
Amazon Stock Is on a Roll. Here’s Why It’s on This Firm’s ‘Best Ideas List.’
|
May 3 |
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
|
May 3 |
Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
|
May 3 |
Analyst unveils Amgen stock price target after weight-loss drug data
|
May 3 |
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
|
May 3 |
Weight-loss drug competition heats up. Is Wegovy in trouble?
|
May 3 |
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
|
May 3 |
Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
|
May 3 |
US STOCKS-Wall St set to open sharply higher on soft jobs data
|